Author Correction: Immune response and protective efficacy of the SARS-CoV-2 recombinant spike protein vaccine S-268019-b in mice.
Saved in:
| Title: | Author Correction: Immune response and protective efficacy of the SARS-CoV-2 recombinant spike protein vaccine S-268019-b in mice. |
|---|---|
| Authors: | Homma T; Laboratory for Bio-Drug Discovery, Shionogi & Co., Ltd., 3-1-1, Futaba-cho, Toyonaka, Osaka, 561-0825, Japan., Nagata N; Department of Pathology, National Institute of Infectious Diseases, 4-7-1, Gakuen, Musashimurayama-shi, Tokyo, 208-0011, Japan., Hashimoto M; Laboratory for Bio-Drug Discovery, Shionogi & Co., Ltd., 3-1-1, Futaba-cho, Toyonaka, Osaka, 561-0825, Japan., Iwata-Yoshikawa N; Department of Pathology, National Institute of Infectious Diseases, 4-7-1, Gakuen, Musashimurayama-shi, Tokyo, 208-0011, Japan., Seki NM; Laboratory for Bio-Drug Discovery, Shionogi & Co., Ltd., 3-1-1, Futaba-cho, Toyonaka, Osaka, 561-0825, Japan., Shiwa-Sudo N; Department of Pathology, National Institute of Infectious Diseases, 4-7-1, Gakuen, Musashimurayama-shi, Tokyo, 208-0011, Japan., Ainai A; Department of Pathology, National Institute of Infectious Diseases, 1-23-1, Toyama, Shinjuku-ku, Tokyo, 162-8640, Japan., Dohi K; Laboratory for Bio-Drug Discovery, Shionogi & Co., Ltd., 3-1-1, Futaba-cho, Toyonaka, Osaka, 561-0825, Japan., Nikaido E; Laboratory for Bio-Modality Research, Shionogi & Co., Ltd., 3-1-1, Futaba-cho, Toyonaka, Osaka, 561-0825, Japan., Mukai A; UMN Pharma Inc., 7F, Tekko Building, 1-8-2, Marunouchi, Chiyoda-ku, Tokyo, 100-0005, Japan., Ukai Y; Laboratory for Bio-Drug Discovery, Shionogi & Co., Ltd., 3-1-1, Futaba-cho, Toyonaka, Osaka, 561-0825, Japan., Nakagawa T; Laboratory for Bio-Drug Discovery, Shionogi & Co., Ltd., 3-1-1, Futaba-cho, Toyonaka, Osaka, 561-0825, Japan., Shimo Y; Laboratory for Drug Discovery and Disease Research, Shionogi & Co., Ltd., 3-1-1, Futaba-cho, Toyonaka, Osaka, 561-0825, Japan., Maeda H; Laboratory for Bio-Drug Discovery, Shionogi & Co., Ltd., 3-1-1, Futaba-cho, Toyonaka, Osaka, 561-0825, Japan., Shirai S; Laboratory for Bio-Drug Discovery, Shionogi & Co., Ltd., 3-1-1, Futaba-cho, Toyonaka, Osaka, 561-0825, Japan., Aoki M; Laboratory for Bio-Drug Discovery, Shionogi & Co., Ltd., 3-1-1, Futaba-cho, Toyonaka, Osaka, 561-0825, Japan., Sonoyama T; Medical Science Department, Shionogi & Co., Ltd., 8F, Nissei East Building, 3-3-16, Imabashi, Chuo-ku, Osaka, 541-0032, Japan., Sato M; UMN Pharma Inc., 7F, Tekko Building, 1-8-2, Marunouchi, Chiyoda-ku, Tokyo, 100-0005, Japan., Fumoto M; Laboratory for Bio-Modality Research, Shionogi & Co., Ltd., 3-1-1, Futaba-cho, Toyonaka, Osaka, 561-0825, Japan., Nagira M; Laboratory for Bio-Drug Discovery, Shionogi & Co., Ltd., 3-1-1, Futaba-cho, Toyonaka, Osaka, 561-0825, Japan., Nakata F; UMN Pharma Inc., 7F, Tekko Building, 1-8-2, Marunouchi, Chiyoda-ku, Tokyo, 100-0005, Japan., Hashiguchi T; Laboratory of Medical Virology, Institute for Life and Medical Sciences, Kyoto University, 53 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.; Department of Virology, Faculty of Medicine, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan., Suzuki T; Department of Pathology, National Institute of Infectious Diseases, 1-23-1, Toyama, Shinjuku-ku, Tokyo, 162-8640, Japan., Omoto S; Laboratory for Bio-Drug Discovery, Shionogi & Co., Ltd., 3-1-1, Futaba-cho, Toyonaka, Osaka, 561-0825, Japan. shinya.oomoto@shionogi.co.jp., Hasegawa H; Center for Influenza and Respiratory Virus Research, National Institute of Infectious Diseases, 4-7-1, Gakuen, Musashimurayama-shi, Tokyo, 208-0011, Japan. hasegawa@niid.go.jp. |
| Source: | Scientific reports [Sci Rep] 2024 Jan 31; Vol. 14 (1), pp. 2599. Date of Electronic Publication: 2024 Jan 31. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38297027 AccessLevel: 2 PubTypeId: unknown PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Author Correction: Immune response and protective efficacy of the SARS-CoV-2 recombinant spike protein vaccine S-268019-b in mice. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Homma+T%22">Homma T</searchLink>; Laboratory for Bio-Drug Discovery, Shionogi & Co., Ltd., 3-1-1, Futaba-cho, Toyonaka, Osaka, 561-0825, Japan.<br /><searchLink fieldCode="AU" term="%22Nagata+N%22">Nagata N</searchLink>; Department of Pathology, National Institute of Infectious Diseases, 4-7-1, Gakuen, Musashimurayama-shi, Tokyo, 208-0011, Japan.<br /><searchLink fieldCode="AU" term="%22Hashimoto+M%22">Hashimoto M</searchLink>; Laboratory for Bio-Drug Discovery, Shionogi & Co., Ltd., 3-1-1, Futaba-cho, Toyonaka, Osaka, 561-0825, Japan.<br /><searchLink fieldCode="AU" term="%22Iwata-Yoshikawa+N%22">Iwata-Yoshikawa N</searchLink>; Department of Pathology, National Institute of Infectious Diseases, 4-7-1, Gakuen, Musashimurayama-shi, Tokyo, 208-0011, Japan.<br /><searchLink fieldCode="AU" term="%22Seki+NM%22">Seki NM</searchLink>; Laboratory for Bio-Drug Discovery, Shionogi & Co., Ltd., 3-1-1, Futaba-cho, Toyonaka, Osaka, 561-0825, Japan.<br /><searchLink fieldCode="AU" term="%22Shiwa-Sudo+N%22">Shiwa-Sudo N</searchLink>; Department of Pathology, National Institute of Infectious Diseases, 4-7-1, Gakuen, Musashimurayama-shi, Tokyo, 208-0011, Japan.<br /><searchLink fieldCode="AU" term="%22Ainai+A%22">Ainai A</searchLink>; Department of Pathology, National Institute of Infectious Diseases, 1-23-1, Toyama, Shinjuku-ku, Tokyo, 162-8640, Japan.<br /><searchLink fieldCode="AU" term="%22Dohi+K%22">Dohi K</searchLink>; Laboratory for Bio-Drug Discovery, Shionogi & Co., Ltd., 3-1-1, Futaba-cho, Toyonaka, Osaka, 561-0825, Japan.<br /><searchLink fieldCode="AU" term="%22Nikaido+E%22">Nikaido E</searchLink>; Laboratory for Bio-Modality Research, Shionogi & Co., Ltd., 3-1-1, Futaba-cho, Toyonaka, Osaka, 561-0825, Japan.<br /><searchLink fieldCode="AU" term="%22Mukai+A%22">Mukai A</searchLink>; UMN Pharma Inc., 7F, Tekko Building, 1-8-2, Marunouchi, Chiyoda-ku, Tokyo, 100-0005, Japan.<br /><searchLink fieldCode="AU" term="%22Ukai+Y%22">Ukai Y</searchLink>; Laboratory for Bio-Drug Discovery, Shionogi & Co., Ltd., 3-1-1, Futaba-cho, Toyonaka, Osaka, 561-0825, Japan.<br /><searchLink fieldCode="AU" term="%22Nakagawa+T%22">Nakagawa T</searchLink>; Laboratory for Bio-Drug Discovery, Shionogi & Co., Ltd., 3-1-1, Futaba-cho, Toyonaka, Osaka, 561-0825, Japan.<br /><searchLink fieldCode="AU" term="%22Shimo+Y%22">Shimo Y</searchLink>; Laboratory for Drug Discovery and Disease Research, Shionogi & Co., Ltd., 3-1-1, Futaba-cho, Toyonaka, Osaka, 561-0825, Japan.<br /><searchLink fieldCode="AU" term="%22Maeda+H%22">Maeda H</searchLink>; Laboratory for Bio-Drug Discovery, Shionogi & Co., Ltd., 3-1-1, Futaba-cho, Toyonaka, Osaka, 561-0825, Japan.<br /><searchLink fieldCode="AU" term="%22Shirai+S%22">Shirai S</searchLink>; Laboratory for Bio-Drug Discovery, Shionogi & Co., Ltd., 3-1-1, Futaba-cho, Toyonaka, Osaka, 561-0825, Japan.<br /><searchLink fieldCode="AU" term="%22Aoki+M%22">Aoki M</searchLink>; Laboratory for Bio-Drug Discovery, Shionogi & Co., Ltd., 3-1-1, Futaba-cho, Toyonaka, Osaka, 561-0825, Japan.<br /><searchLink fieldCode="AU" term="%22Sonoyama+T%22">Sonoyama T</searchLink>; Medical Science Department, Shionogi & Co., Ltd., 8F, Nissei East Building, 3-3-16, Imabashi, Chuo-ku, Osaka, 541-0032, Japan.<br /><searchLink fieldCode="AU" term="%22Sato+M%22">Sato M</searchLink>; UMN Pharma Inc., 7F, Tekko Building, 1-8-2, Marunouchi, Chiyoda-ku, Tokyo, 100-0005, Japan.<br /><searchLink fieldCode="AU" term="%22Fumoto+M%22">Fumoto M</searchLink>; Laboratory for Bio-Modality Research, Shionogi & Co., Ltd., 3-1-1, Futaba-cho, Toyonaka, Osaka, 561-0825, Japan.<br /><searchLink fieldCode="AU" term="%22Nagira+M%22">Nagira M</searchLink>; Laboratory for Bio-Drug Discovery, Shionogi & Co., Ltd., 3-1-1, Futaba-cho, Toyonaka, Osaka, 561-0825, Japan.<br /><searchLink fieldCode="AU" term="%22Nakata+F%22">Nakata F</searchLink>; UMN Pharma Inc., 7F, Tekko Building, 1-8-2, Marunouchi, Chiyoda-ku, Tokyo, 100-0005, Japan.<br /><searchLink fieldCode="AU" term="%22Hashiguchi+T%22">Hashiguchi T</searchLink>; Laboratory of Medical Virology, Institute for Life and Medical Sciences, Kyoto University, 53 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.; Department of Virology, Faculty of Medicine, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.<br /><searchLink fieldCode="AU" term="%22Suzuki+T%22">Suzuki T</searchLink>; Department of Pathology, National Institute of Infectious Diseases, 1-23-1, Toyama, Shinjuku-ku, Tokyo, 162-8640, Japan.<br /><searchLink fieldCode="AU" term="%22Omoto+S%22">Omoto S</searchLink>; Laboratory for Bio-Drug Discovery, Shionogi & Co., Ltd., 3-1-1, Futaba-cho, Toyonaka, Osaka, 561-0825, Japan. shinya.oomoto@shionogi.co.jp.<br /><searchLink fieldCode="AU" term="%22Hasegawa+H%22">Hasegawa H</searchLink>; Center for Influenza and Respiratory Virus Research, National Institute of Infectious Diseases, 4-7-1, Gakuen, Musashimurayama-shi, Tokyo, 208-0011, Japan. hasegawa@niid.go.jp. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101563288%22">Scientific reports</searchLink> [Sci Rep] 2024 Jan 31; Vol. 14 (1), pp. 2599. <i>Date of Electronic Publication: </i>2024 Jan 31. – Name: TypePub Label: Publication Type Group: TypPub Data: Published Erratum – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101563288 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2045-2322 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220452322%22">20452322 </searchLink><i>NLM ISO Abbreviation: </i>Sci Rep <i>Subsets: </i>MEDLINE; PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38297027 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41598-024-52772-3 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2599 Titles: – TitleFull: Author Correction: Immune response and protective efficacy of the SARS-CoV-2 recombinant spike protein vaccine S-268019-b in mice. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Homma T – PersonEntity: Name: NameFull: Nagata N – PersonEntity: Name: NameFull: Hashimoto M – PersonEntity: Name: NameFull: Iwata-Yoshikawa N – PersonEntity: Name: NameFull: Seki NM – PersonEntity: Name: NameFull: Shiwa-Sudo N – PersonEntity: Name: NameFull: Ainai A – PersonEntity: Name: NameFull: Dohi K – PersonEntity: Name: NameFull: Nikaido E – PersonEntity: Name: NameFull: Mukai A – PersonEntity: Name: NameFull: Ukai Y – PersonEntity: Name: NameFull: Nakagawa T – PersonEntity: Name: NameFull: Shimo Y – PersonEntity: Name: NameFull: Maeda H – PersonEntity: Name: NameFull: Shirai S – PersonEntity: Name: NameFull: Aoki M – PersonEntity: Name: NameFull: Sonoyama T – PersonEntity: Name: NameFull: Sato M – PersonEntity: Name: NameFull: Fumoto M – PersonEntity: Name: NameFull: Nagira M – PersonEntity: Name: NameFull: Nakata F – PersonEntity: Name: NameFull: Hashiguchi T – PersonEntity: Name: NameFull: Suzuki T – PersonEntity: Name: NameFull: Omoto S – PersonEntity: Name: NameFull: Hasegawa H IsPartOfRelationships: – BibEntity: Dates: – D: 31 M: 01 Text: 2024 Jan 31 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 2045-2322 Numbering: – Type: volume Value: 14 – Type: issue Value: 1 Titles: – TitleFull: Scientific reports Type: main |
| ResultId | 1 |